ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

Search

Biotage AB

Slēgts

141.9 0.35

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

141.4

Max

142.1

Galvenie mērījumi

By Trading Economics

Ienākumi

-154M

4M

Pārdošana

-197M

385M

P/E

Sektora vidējais

44.606

24.598

EPS

0.325

Dividenžu ienesīgums

1.16

Peļņas marža

1.039

Darbinieki

622

EBITDA

-194M

28M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.16%

4.30%

Nākamie ieņēmumi

2025. g. 16. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

4.1B

11B

Iepriekšējā atvēršanas cena

141.55

Iepriekšējā slēgšanas cena

141.9

Biotage AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. apr. 06:50 UTC

Iegādes, apvienošanās, pārņemšana

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

2025. g. 22. apr. 06:04 UTC

Iegādes, apvienošanās, pārņemšana

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

2025. g. 22. apr. 06:03 UTC

Iegādes, apvienošanās, pārņemšana

KKR: Biotage Board Recommends Shareholders Accept Offer

2025. g. 22. apr. 06:02 UTC

Iegādes, apvienošanās, pārņemšana

KKR: Offer Values Biotage at SEK11.61B

2025. g. 22. apr. 06:02 UTC

Iegādes, apvienošanās, pārņemšana

KKR Makes SEK145 a Share Bid For Biotage

Salīdzinājums

Cenas izmaiņa

Biotage AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.